Voyager Therapeutics (VT6) Q3 2022 Earnings Report

5 Followers

DE:VT6 Q3 2022 EPS Results

Actual EPS: EUR 0.40
Consensus EPS: -EUR 0.28
Beat/Miss: Beat by +EUR 0.69
One Year Ago EPS: -EUR 0.60

DE:VT6 Q3 2022 Revenue Results

Actual Revenue: EUR 36.79M
Expected Revenue: EUR 8.43M
Beat/Miss: Beat by +EUR 28.36M
YoY Revenue Growth: +2672.33%

Earnings Announcement Details

Quarter: Q3 2022
Date: 11/08/2022
Time: Before Open
Conference Call: Tuesday, November 8, 2022

DE:VT6 Upcoming Earnings

Voyager Therapeutics's next earnings date is estimated for March 9, 2027, based on past reporting schedules.

Q3 2022 Earnings Call Audio

DE:VT6 Q3 2022 Earnings Call

0:00 / 0:00

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:VT6 Earnings History

DE:VT6 earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 09, 2027	2026 (Q4)	-0.31-	-0.41	―	―
Nov 05, 2026	2026 (Q3)	-0.38-0.36	-0.42	14.89% (+0.06)
Aug 06, 2026	2026 (Q2)	-0.43-0.36	-0.51	29.82% (+0.15)
May 07, 2026	2026 (Q1)	-0.49-0.42	-0.47	11.32% (+0.05)
Mar 09, 2026	2025 (Q4)	-0.46-0.41	-0.53	22.03% (+0.12)
Nov 10, 2025	2025 (Q3)	-0.47-0.42	-0.14	-193.75% (-0.28)
Aug 06, 2025	2025 (Q2)	-0.47-0.51	-0.16	-216.67% (-0.35)
May 06, 2025	2025 (Q1)	-0.40-0.47	-0.18	-165.00% (-0.30)
Mar 11, 2025	2024 (Q4)	-0.33-0.53	1.12	-147.20% (-1.65)
Nov 12, 2024	2024 (Q3)	-0.40-0.14	-0.53	72.88% (+0.39)
Aug 06, 2024	2024 (Q2)	-0.37-0.16	-0.46	64.71% (+0.30)
May 13, 2024	2024 (Q1)	-0.39-0.18	2.63	-106.80% (-2.81)
Feb 28, 2024	2023 (Q4)	-0.261.12	-0.55	304.92% (+1.67)
Nov 06, 2023	2023 (Q3)	-0.52-0.53	0.4	-231.11% (-0.93)
Aug 03, 2023	2023 (Q2)	-0.51-0.46	-0.45	-2.00% (-0.01)
May 09, 2023	2023 (Q1)	-0.292.63	-0.5	625.00% (+3.13)
Mar 07, 2023	2022 (Q4)	-0.49-0.55	0.13	-506.67% (-0.68)
Nov 08, 2022	2022 (Q3)	-0.280.40	-0.6	167.16% (+1.00)
Aug 04, 2022	2022 (Q2)	-0.43-0.45	-0.72	37.50% (+0.27)
May 04, 2022	2022 (Q1)	-0.33-0.50	-0.52	3.45% (+0.02)
Mar 08, 2022	2021 (Q4)	-0.560.13	-0.39	134.88% (+0.52)
Nov 02, 2021	2021 (Q3)	-0.67-0.60	2.03	-129.52% (-2.63)
May 10, 2021	2021 (Q1)	―-0.52	-0.59	12.12% (+0.07)
Feb 25, 2021	2020 (Q4)	―-0.39	-0.3	-26.47% (-0.08)
Nov 09, 2020	2020 (Q3)	―2.03	-0.37	653.66% (+2.40)
Aug 10, 2020	2020 (Q2)	―-0.21	0.26	-179.31% (-0.47)
May 06, 2020	2020 (Q1)	―-0.59	-0.73	18.52% (+0.13)
Mar 03, 2020	2019 (Q4)	―-0.30	-0.63	51.43% (+0.32)
Nov 06, 2019	2019 (Q3)	―-0.37	-0.56	34.92% (+0.20)
Aug 09, 2019	2019 (Q2)	―0.26	-0.72	136.25% (+0.98)
May 07, 2019	2019 (Q1)	―-0.73	-0.56	-28.57% (-0.16)
Feb 26, 2019	2018 (Q4)	―-0.63	-0.36	-75.00% (-0.27)
Nov 07, 2018	2018 (Q3)	―-0.56	-0.8	29.21% (+0.23)
Aug 07, 2018	2018 (Q2)	―-0.72	-0.65	-9.59% (-0.06)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Voyager Therapeutics earnings date